Neumann, Susanne
Porritt, Michelle J.
Osman, Ahmed M.
Kuhn, H. Georg
Funding for this research was provided by:
Vetenskapsrådet (2019-01637)
Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-726541)
Stroke-Riksförbundet
Barncancerfonden
Article History
Received: 21 November 2019
Accepted: 9 July 2020
First Online: 23 July 2020
Competing interests
: M.J.P. has contributed to the work performed while employed by University of Gothenburg and had at that time no affiliation to Astra Zeneca. She is currently employed at Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. All other authors (S.N., A.M.O. and H.G.K.) declare no competing interest.